- 2017 Japan Society for Equilibrium Research guideline on classification, diagnostic criteria, and management of benign paroxysmal positional vertigo
- Latest American Physical Therapy Association guideline on vestibular rehabilitation for peripheral vestibular hypofunction
- 2017 American Physical Therapy Association practice guidelines on dizziness
- 2017 American Academy of Otolaryngology-Head and Neck Surgery Practice Guideline included
Latest Updates
- 2017 Japan Society for Equilibrium Research guideline on classification, diagnostic criteria, and management of benign paroxysmal positional vertigo
- Latest American Physical Therapy Association guideline on vestibular rehabilitation for peripheral vestibular hypofunction
- 2017 American Physical Therapy Association practice guidelines on dizziness
- 2017 American Academy of Otolaryngology-Head and Neck Surgery Practice Guideline included
- 2017 Japan Society for Equilibrium Research guideline on classification, diagnostic criteria, and management of benign paroxysmal positional vertigo
- Latest American Physical Therapy Association guideline on vestibular rehabilitation for peripheral vestibular hypofunction
- 2017 American Physical Therapy Association practice guidelines on dizziness
- 2017 American Academy of Otolaryngology-Head and Neck Surgery Practice Guideline included
Surgical Management of Benign and Malignant Colorectal Disease in the Immunocompromised Patient
- Immunosuppression alters colorectal disease
- Immunosuppressive therapy for inflammatory bowel disease may worsen postoperative outcomes
- Diverticulitis, even if uncomplicated, should be treated with a surgical resection in patients who have had a solid-organ transplantation
- Typhlitis may mimic appendicitis in immunocompromised patients but should not be managed with surgery
- Certain neoplasms are increased in the setting of immunosuppression
Surgical Management of Benign and Malignant Colorectal Disease in the Immunocompromised Patient
- Immunosuppression alters colorectal disease
- Immunosuppressive therapy for inflammatory bowel disease may worsen postoperative outcomes
- Diverticulitis, even if uncomplicated, should be treated with a surgical resection in patients who have had a solid-organ transplantation
- Typhlitis may mimic appendicitis in immunocompromised patients but should not be managed with surgery
- Certain neoplasms are increased in the setting of immunosuppression
Metabolic Response to Critical Illness - Part 2
- Use of growth hormone for manipulation of metabolic response and muscle characteristics. This in combination with early physical therapy/exercise aids in preservation.
- Anti-cytokine antibodies for partial attenuation of metabolic response. These approaches have elucidated the complexity of mechanisms leading to the metabolic response of critically ill patients.
- Relatively recent adoption of the important role of the gut in metabolic response. This includes production of mediators and functioning as a barrier to bacteria which dramatically affect severity of metabolic response.
Urogenital Fistulas and Female Urethral Diverticula
- For iatrogenic vesicovaginal fistula, delaying repair until healing has occurred is no longer mandatory, and outcomes for immediate repair are comparable to delayed repairs.
- Concomitant stress incontinence surgery with autologous fascial pubovaginal sling at the same time as repair of complex urethral diverticula appears to be safe and effective.
- MRI is a valuable tool for surgical planning and is recommended prior to urethral diverticulectomy.
Medications and Botulinum Toxin for Overactive Bladder
- Emerging role of beta agonist therapy for treatment of OAB
- The pharmacologic use of onabotulinumtoxinA (Botox®) upgraded to strongest rating of “standard" (strength of evidence grade B) by the amended 2014 AUA/SUFU guidelines.
- Studies reporting trigonal injections of Botox may be associated with superior continence rates
